Latest filing published 05 Aug 2024 for Olema Pharmaceuticals, Inc., €7.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -17.5%Entry US$11.44 · Close at T+365 US$9.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paradigm Biocapital Advisors LP: trading record in brief
Paradigm Biocapital Advisors LP appears in our data through filings on Olema Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 6 December 2023 and the latest from 1 August 2024.
In open-market terms, that means 1 purchase worth €1.1M on one side and 2 sales worth €33.2M on the other. Netting one side against the other leaves €32.1M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2024 to date brings no purchases and 2 sales.
The record was last updated on 5 August 2024 with an open-market sale (€7.3M) in Olema Pharmaceuticals, Inc. The most recent open-market purchase was published on 8 December 2023, 1,066 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paradigm Biocapital Advisors LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 529,501 shares@ US$14.91521.4% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-085835:1
- 1,870,499 shares@ US$14.91596.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-085835:0
- 100,000 shares@ US$11.604.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-23-124717:0Canonical exit: 5 Mar 2024 (T+90)
3 of 3 declarations
